Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
“other population-based studies including the Aging, Demographics, and Memory Study (ADAMS), a nationally representative sample of older adults [117,118], Based on estimates from ADAMS, 14 percent of people age 71 and older in the United States have dementia [117].”
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
“The best approach would be a survey of a nationally representative sample, but to our knowledge such studies have only been carried out in the USA (yet on a very small sample) [47] and Canada [29].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
“In addition to estimates from CHAP, the national prevalence of AD and all forms of dementia has been estimated from other population-based studies, including the Aging, Demographics, and Memory Study (ADAMS), a nationally representative sample of older adults [85,86].”
Influential2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
“The Aging, Demographics, and Memory Study determined US prevalence of AD dementia in 2001–2003 using a nationally representative sample.(18) That study found lower prevalence than estimated in the earlier CHAP article.”
MethodLong-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Self-citation2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
“National estimates of the prevalence of all dementias are not available from CHAP, but they are available from other population-based studies including the Aging, Demographics, and Memory Study (ADAMS), a nationally representative sample of older adults [160,161].”
Influential2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Cohort Profile: the Health and Retirement Study (HRS)
Sonnega, A., Faul, J. D., Ofstedal, M. B., Langa, K. M., Phillips, J. W., & Weir, D. R. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu067 · Cited by 2,318
“The addition of the Aging Demographic, and Memory Study (ADAMS) beginning in 2001, provided the first national data on the prevalence of dementia and cognitive impairment.(31,32) Other studies report on factors that may influence cognitive change,(33,34) the consequences of cognitive decline(35) and the monetary costs…”
Self-citation2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
“Based on estimates fromADAMS, among people age 71 and older, 16 percent of women have Alzheimer’s or other dementias compared with 11 percent of men [148].”
InfluentialA mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
“1016/S0140-6736(05)67889-0 [202] Plassman, B.”
BackgroundMonetary Costs of Dementia in the United States
Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1204629 · Cited by 1,484
Self-citationMohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
“Based on estimates fromADAMS, among people age 71 and older, 16 percent of women have Alzheimer’s or other dementias compared with 11 percent of men [138,157].”
InfluentialFragala, M. S., Cadore, E. L., Dorgo, S., Izquierdo, M., Kraemer, W. J., Peterson, M. D., & Ryan, E. D. (2019) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003230 · Cited by 1,290
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
“7%.(4) Worldwide, the global prevalence of dementia was estimated to be 3.”
BackgroundMatthews, K. A., Xu, W., Gaglioti, A. H., Holt, J. B., Croft, J. B., Mack, D., & McGuire, L. C. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3063 · Cited by 1,124
“Although AD is the most common type of ADRD, the prevalence of vascular dementia is higher in African Americans; this is thought to be secondary to known disparities in risk factors for vascular dementia such as cardiovascular disease.”
BackgroundMethodInfluential2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
Thies, W., & Bleiler, L. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 982
Crimmins, E. M., Kim, J. K., Langa, K. M., & Weir, D. R. (2011) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/gbr048 · Cited by 1,056
“The ADAMS data, which have been weighted to represent the same national population as the HRS, have also been used to estimate the national prevalence of dementia (13.7% of the age 71+ population) and CIND (22%; Plassman et al., 2007, 2008).”
MethodInfluentialSelf-citation2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
“Some studies suggest that differences based on race and ethnicity do not persist in detailed analyses that account for these factors [61,116].”
InfluentialClinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
“for the higher prevalence among women may be that they live longer, on average, than men.(44,45) By contrast, incidence”
Dementia and Cognitive Impairment
Hugo, J., & Ganguli, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.001 · Cited by 902
2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
“9% of people aged 71 years in the United States have dementia [43].”
InfluentialMissed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
“9% of American adults over age 70 have some form of dementia, most commonly due to Alzheimer disease.(1) According to the Alzheimer’s Association, the number of older adults with Alzheimer type dementia will have increased over three-fold by the year 2050.”
BackgroundPrevalence of Cognitive Impairment without Dementia in the United States
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00005 · Cited by 929
“In the 71- to 79-year age group, 16% had cognitive impairment without dementia, whereas an additional 5% had dementia (11), suggesting that more than 1 of 5 individuals in this age group has cognitive impairment.”
BackgroundResultInfluentialSelf-citationChow, W. B., Rosenthal, R. A., Merkow, R. P., Ko, C. Y., & Esnaola, N. F. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.06.017 · Cited by 902
“9%, respectively.(15,16) The prevalence of dementia increases exponentially with increasing age over 65 years.”
BackgroundCreavin, S. T., Wisniewski, S., Noel-Storr, A. H., Trevelyan, C. M., Hampton, T., Rayment, D., Thom, V. M., Nash, K. J. E., Elhamoui, H., Milligan, R., et al. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011145.pub2 · Cited by 820
A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012
Langa, K. M., Larson, E. B., Crimmins, E. M., Faul, J. D., Levine, D. A., Kabeto, M. U., & Weir, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6807 · Cited by 910
Self-citationDysphagia in the elderly: management and nutritional considerations
Crary, M., Sura, L., Madhavan, A., & Carnaby-Mann, G. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s23404 · Cited by 813
“Prevalence of dementia increases to over 30% beyond 85 years of age,(16) and over 37% beyond 90 years.(17) Common complications of dysphagia in both stroke and dementia include malnutrition and pneumonia.”
BackgroundInequalities in dementia incidence between six racial and ethnic groups over 14 years
Mayeda, E. R., Glymour, M. M., Quesenberry, C. P., & Whitmer, R. A. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.007 · Cited by 883
“Dementia risk is reported to be up to twice as high for African-Americans compared with whites [5,12–15].”
BackgroundApolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857
Global Epidemiology of Dementia: Alzheimer’s and Vascular Types
Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014) · BioMed Research International · doi:10.1155/2014/908915 · Cited by 751
“Based on the Aging Demographics and Memory Study (ADAMS) about 14% of people aged more than 71 years in USA have dementia [30].”
MethodLim, A. S. P., Kowgier, M., Yu, L., Buchman, A. S., & Bennett, D. A. (2013) · Sleep · doi:10.5665/sleep.2802 · Cited by 793
2010 Alzheimer's disease facts and figures
Alzheimer's Association (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.009 · Cited by 684
“Participants in ADAMS were drawn from the HRS and, with weighting, constitute a nationally representative sample of Americans in that age group [12].”
InfluentialA network diffusion model of disease progression in dementia
Raj, A., Kuceyeski, A., & Weiner, M. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.040 · Cited by 723
“These data were taken from the following studies: (Harvey 2003; Ratnavalli et al., 2002; Kobayashi et al., 2009; Jellinger and Attems, 2010; Kukull et al., 2002; Morrison, 2010; Di Carlo et al., 2002; Plassman et al., 2007).”
Retooling for an aging America: building the health care workforce
(2009) · Choice Reviews Online · doi:10.5860/choice.46-5066 · Cited by 688
Physical exercise in the prevention and treatment of Alzheimer's disease
De la Rosa, A., Olaso-Gonzalez, G., Arc-Chagnaud, C., Millan, F., Salvador-Pascual, A., García-Lucerga, C., Blasco-Lafarga, C., Garcia-Dominguez, E., Carretero, A., Correas, A. G., et al. (2020) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.01.004 · Cited by 595
2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
Kirova, A.-M., Bays, R. B., & Lagalwar, S. (2015) · BioMed Research International · doi:10.1155/2015/748212 · Cited by 649
“…Alzheimer’s Disease Anna-Mariya Kirova,1,2 Rebecca B. Bays,1 and Sarita Lagalwar2 1Department of Psychology, Skidmore College, 815 North Broadway, Saratoga Springs, NY 12866, USA 2Neuroscience Program, Skidmore College, 815 North Broadway, Saratoga Springs, NY 12866, USA Correspondence should be…”
BackgroundGottesman, R. F., Albert, M. S., Alonso, A., Coker, L. H., Coresh, J., Davis, S. M., Deal, J. A., McKhann, G. M., Mosley, T. H., Sharrett, A. R., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1658 · Cited by 633
2009 Alzheimer's disease facts and figures
Alzheimer's Association (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.03.001 · Cited by 543
“9, AD accounts for 70% of all cases of dementia in Americans aged 71 years and older [2].”
InfluentialFunctional brain connectivity using fMRI in aging and Alzheimer’s disease
Dennis, E. L., & Thompson, P. M. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9249-6 · Cited by 583
“Nearly 14 % of individuals over age 71 suffer from some form of dementia, and Alzheimer's disease is the most common (Plassman et al. 2007).”
Vann Jones, S. A., & O'Brien, J. T. (2014) · Psychological Medicine · doi:10.1017/s0033291713000494 · Cited by 546
“…Tognoni et al. 2005 Yokota et al. 2005 Galasko et al. 2007 Shinagawa et al. 2007 Gascon-Bayarri et al. 2007 Yoshida et al. 2011 Molero et al. 2007 Plassman et al. 2007 Gurvit et al. 2008 Jhoo et al. 2008 Arslantas et al. 2009 Kim et al. 2011 Yusuf et al. 2011 (b) Population incidence…”
BackgroundManly, J. J., Jones, R. N., Langa, K. M., Ryan, L. H., Levine, D. A., McCammon, R., Heeringa, S. G., & Weir, D. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3543 · Cited by 560
Self-citationAssociation between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535
“6) Center for Epidemiologic Studies Depression Scale score, median (IQR) 0 (0-1) 1 (0-2) 6 (3-10) 8 (4-13)”
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years
Fillenbaum, G. G., van Belle, G., Morris, J. C., Mohs, R. C., Mirra, S. S., Davis, P. C., Tariot, P. N., Silverman, J. M., Clark, C. M., Welsh-Bohmer, K. A., et al. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.08.005 · Cited by 482
Vitamin D and Risk of Cognitive Decline in Elderly Persons
Llewellyn, D. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.173 · Cited by 459
Physical exercise and cognitive performance in the elderly: Current perspectives.
Kirk-Sanchez, N., & McGough, E. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s39506 · Cited by 465
Exergaming and Older Adult Cognition
Anderson-Hanley, C., Arciero, P. J., Brickman, A. M., Nimon, J. P., Okuma, N., Westen, S. C., Merz, M. E., Pence, B. D., Woods, J. A., Kramer, A. F., et al. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.10.016 · Cited by 464
“Purpose: To test the followinghypotheses: (1) stationary cyclingwith virtual reality tours (“cybercycle”) will enhance executive function and clinical status more than traditional exercise; (2) exercise effort will explain improvement; and (3) brain-derived neurotrophic growth factor (BDNF) will increase.”
Effect of Tai Chi on Cognitive Performance in Older Adults: Systematic Review and Meta‐Analysis
Wayne, P. M., Walsh, J. N., Taylor‐Piliae, R. E., Wells, R. E., Papp, K. V., Donovan, N. J., & Yeh, G. Y. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12611 · Cited by 425
“4 million have dementia.(1) Between 2005 and 2009, the worldwide cost of dementia increased by approximately 34%.”
BackgroundThe prevalence of dementia in urban and rural areas of China
Jia, J., Wang, F., Wei, C., Zhou, A., Jia, X., Li, F., Tang, M., Chu, L., Zhou, Y., Zhou, C., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.012 · Cited by 441
“Consistent with previous investigations in China and other countries [2,5,30], our study confirms that older age is the strongest risk factor for AD and VaD in both urban and rural populations.”
ResultCognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Kalantarian, S., Stern, T. A., Mansour, M., & Ruskin, J. N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00007 · Cited by 425
“The prevalence of cognitive impairment and dementia is also increasing in association with the increased longevity of the population and the accumulation of risk factors for cognitive impairment (2).”
BackgroundLin, J. S., O’Connor, E., Rossom, R. C., Perdue, L. A., & Eckstrom, E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-9-201311050-00730 · Cited by 410
“Dementia, a decline in cognitive function severe enough to affect social or occupational functioning (1), can be due to Alzheimer disease (AD), vascular dementia, frontotemporal dementia, dementia with Lewy bodies, Parkinson disease with dementia, dementia of mixed cause, or many rarer causes (2).”
BackgroundMild Cognitive Impairment and Mild Dementia: A Clinical Perspective
Knopman, D. S., & Petersen, R. C. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.06.019 · Cited by 392
Power, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422
National estimates of the prevalence of Alzheimer's disease in the United States
Brookmeyer, R., Evans, D. A., Hebert, L., Langa, K. M., Heeringa, S. G., Plassman, B. L., & Kukull, W. A. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.007 · Cited by 399
“The second approach relies on representative cross-sectional prevalence surveys of AD [2,6].”
Self-citationSchäfer, I., von Leitner, E.-C., Schön, G., Koller, D., Hansen, H., Kolonko, T., Kaduszkiewicz, H., Wegscheider, K., Glaeske, G., & van den Bussche, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015941 · Cited by 389
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
Brookmeyer, R., Abdalla, N., Kawas, C. H., & Corrada, M. M. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.10.009 · Cited by 406
“The first approach is based on probability-based nationally representative prevalence surveys such as the Aging, Demographics and Memory Study [11].”
MethodGoldman, J. S., Hahn, S. E., Catania, J. W., Larusse-Eckert, S., Butson, M. B., Rumbaugh, M., Strecker, M. N., Roberts, J. S., Burke, W., Mayeux, R., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821d69b8 · Cited by 393
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Kales, H. C., Kim, H. M., Zivin, K., Valenstein, M., Seyfried, L. S., Chiang, C., Cunningham, F., Schneider, L. S., & Blow, F. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030347 · Cited by 384
Contribution of Alzheimer disease to mortality in the United States
James, B. D., Leurgans, S. E., Hebert, L. E., Scherr, P. A., Yaffe, K., & Bennett, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000240 · Cited by 361
Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo
DuBoff, B., Götz, J., & Feany, M. B. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.026 · Cited by 377
The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life
Kelley, A. S., McGarry, K., Gorges, R., & Skinner, J. S. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0381 · Cited by 373
“This probability is provided by the HRS and reflects an algorithm formulated by its investigators that is based on multiple cognitive measures; methods are reported elsewhere (9, 14).”
MethodAn Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.03.014 · Cited by 342
Yaffe, K., Falvey, C., Harris, T. B., Newman, A., Satterfield, S., Koster, A., Ayonayon, H., Simonsick, E., & Study, F. T. H. A. (2013) · BMJ · doi:10.1136/bmj.f7051 · Cited by 363
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
“However, this level of education is not unusual for this sample and education was not found to be a multivariate predictor of agreement, though education has been found to be a significant predictor of dementia in past work using ADAMS [7].”
InfluentialSelf-citationThe Disproportionate Impact Of Dementia On Family And Unpaid Caregiving To Older Adults
Kasper, J. D., Freedman, V. A., Spillman, B. C., & Wolff, J. L. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0536 · Cited by 354
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
“VaD accounts for about 17–20% of all dementia patients making it the second leading form of dementia after Alzheimer’s disease (AD), and is prevalent among the older population [1].”
BackgroundThe Mental Health and Substance Use Workforce for Older Adults: In Whose Hands?
Eden, J., Maslow, K., Le, M., & Blazer, D. G. (2013) · Cited by 364
Hsu, W.-Y., Ku, Y., Zanto, T. P., & Gazzaley, A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.016 · Cited by 330
“Alzheimer's disease (AD) is a neurodegenerative disease manifested by cognitive impairment and behavioral derangement, and AD is the most common cause of dementia in older adults (Plassman et al., 2007).”
BackgroundIncidence of Parkinson disease in North America
Willis, A. W., Roberts, E., Beck, J. C., Fiske, B., Ross, W., Savica, R., Van Den Eeden, S. K., Tanner, C. M., Marras, C., on behalf of the Parkinson’s Foundation P4 Group, et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00410-y · Cited by 341
“Symptomatic cognitive dysfunction or dementia, due to Alzheimer disease, vascular dementia, toxic or metabolic cognitive dysfunction, increases with age 52 and becomes very prevalent in the 8 th decade and beyond 12,53,54 .”
McClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.188136 · Cited by 339
Prevalence of dementia subtypes in United States Medicare fee‐for‐service beneficiaries, 2011–2013
Goodman, R. A., Lochner, K. A., Thambisetty, M., Wingo, T. S., Posner, S. F., & Ling, S. M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.002 · Cited by 326
“We also note that a comparison of dementia diagnosis in ADAMS [8] and Medicare claims found that Medicare claims and ADAMS agreed on 85% of subjects and had a kappa statistic of 0.70 [16], a finding that provides some assessment of the constancy of diagnostic codes and clinical diagnosis.”
InfluentialSex and Gender Differences in Alzheimer's Disease Dementia.
Mielke, M. M. (2018) · PubMed · Cited by 478
Knopman, D. S., Gottesman, R. F., Sharrett, A. R., Wruck, L. M., Windham, B. G., Coker, L., Schneider, A. L. C., Hengrui, S., Alonso, A., Coresh, J., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.002 · Cited by 313
“In contrast to some studies [1,31,41] but not others [38,40,42], there were no consistent differences in dementia prevalence between men and women, but men were consistently more likely to receive a diagnosis of MCI [32].”
ResultYaffe, K., Ackerson, L., Tamura, M. K., Le Blanc, P., Kusek, J. W., Sehgal, A. R., Cohen, D., Anderson, C., Appel, L., DeSalvo, K., et al. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02670.x · Cited by 313
“Both conditions are associated with greater healthcare use and poorer quality of life and are of increasing public health significance.(1,2) Whether CKD is associated with accelerated cognitive aging has not been rigorously addressed.”
BackgroundGlucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Mehdi, S. F., Pusapati, S., Anwar, M. S., Lohana, D., Kumar, P., Nandula, S. A., Nawaz, F. K., Tracey, K., Yang, H., LeRoith, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148209 · Cited by 317
Long-Term Care Services in the United States: 2013 Overview.
Harris-Kojetin, L., Sengupta, M., Park-Lee, E. Y., & Valverde, R. (2013) · PubMed · Cited by 316
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Mahmood, D. F. D., Abderrazak, A., El Hadri, K., Simmet, T., & Rouis, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4757 · Cited by 305
“Alzheimer’s disease represents the most common neuro-degenerative disease, accounting for more than 50% of all types of dementia (337).”
Antidepressants for agitation and psychosis in dementia
Seitz, D. P., Adunuri, N., Gill, S. S., Gruneir, A., Herrmann, N., & Rochon, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008191.pub2 · Cited by 304
The challenges of human population ageing
Sander, M., Oxlund, B., Jespersen, A., Krasnik, A., Mortensen, E. L., Westendorp, R. G. J., & Rasmussen, L. J. (2015) · Age and Ageing · doi:10.1093/ageing/afu189 · Cited by 290
Chen, X.-Q., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 289
Jack, C. R., Therneau, T. M., Weigand, S. D., Wiste, H. J., Knopman, D. S., Vemuri, P., Lowe, V. J., Mielke, M. M., Roberts, R. O., Machulda, M. M., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1971 · Cited by 300
Neuropharmacological Review of the Nootropic Herb Bacopa monnieri
Aguiar, S., & Borowski, T. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1431 · Cited by 295
Apostolova, L. G. (2016) · Continuum · doi:10.1212/con.0000000000000307 · Cited by 198
“According to ADAMS, 16% of women, but only 11% of men, live with dementia after 71 years of age.(5) While it is true that women live longer than men, this alone does not explain the discrepancy.”
BackgroundAtrial fibrillation and incidence of dementia: A systematic review and meta-analysis
Kwok, C. S., Loke, Y. K., Hale, R., Potter, J. F., & Myint, P. K. (2011) · Neurology · doi:10.1212/wnl.0b013e31820f2e38 · Cited by 283
In Vivo Seeding and Cross-Seeding of Localized Amyloidosis
Oskarsson, M. E., Paulsson, J. F., Schultz, S. W., Ingelsson, M., Westermark, P., & Westermark, G. T. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.016 · Cited by 281
Effects of hearing and vision impairments on the Montreal Cognitive Assessment
Dupuis, K., Pichora-Fuller, M. K., Chasteen, A. L., Marchuk, V., Singh, G., & Smith, S. L. (2015) · Aging, Neuropsychology, and Cognition · doi:10.1080/13825585.2014.968084 · Cited by 278
“Given the rapidly growing population of older individuals being diagnosed with cognitive impairment (14% of Americans aged 71 years and older; Plassman et al., 2007), incorrect diagnoses could have devastating implications not only for patients and their family members but also for the health care…”
BackgroundFiest, K. M., Roberts, J. I., Maxwell, C. J., Hogan, D. B., Smith, E. E., Frolkis, A., Cohen, A., Kirk, A., Pearson, D., Pringsheim, T., et al. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.36 · Cited by 272
Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States
Chen, C., & Zissimopoulos, J. M. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.08.009 · Cited by 269
“In the United States, there is a variation in changes over time of educational attainment, prevalence and management of chronic diseases, and behaviors associated with poor cardiovascular health among racial and ethnic groups [29,30].”
BackgroundInfluentialAlzheimer’s pathogenic mechanisms and underlying sex difference
Zhu, D., Montagne, A., & Zhao, Z. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03830-w · Cited by 250
“Hence, the men included in the study were the ones with a healthier cardiovascular risk profile and survived beyond age 65 (men have a higher rate of death from cardiovascular disease in middle age than women) and thus a lower risk for dementia [40, 41].”
BackgroundAtrial fibrillation and the risk of incident dementia: A meta-analysis
Santangeli, P., Di Biase, L., Bai, R., Mohanty, S., Pump, A., Cereceda Brantes, M., Horton, R., Burkhardt, J. D., Lakkireddy, D., Reddy, Y. M., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.07.026 · Cited by 272
Prevalence of depression among older Americans: the Aging, Demographics and Memory Study
Steffens, D. C., Fisher, G. G., Langa, K. M., Potter, G. G., & Plassman, B. L. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209990044 · Cited by 272
Self-citationLike cognitive function, decision making across the life span shows profound age-related changes
Tymula, A., Rosenberg Belmaker, L. A., Ruderman, L., Glimcher, P. W., & Levy, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309909110 · Cited by 279
“Over 13% of adults over 71 y old have some quantifiable dementia (14), and 22.”
Background
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.